APPLICATION OF FDA-APPROVED MEMANTINE AND NEWER NITROMEMANTINE DERIVATIVES TO TREAT NEUROLOGICAL MANIFESTATIONS IN RODENT MODELS OF TUBEROUS SCLEROSI
$195,000FY2013Department of DefenseDOD
Sanford Burnham Prebys Medical Discovery Institute, La Jolla CA